Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vinpocetine is a synthetic derivative of the alkaloid vincamine, originally extracted from the periwinkle plant (Vinca minor). It has been studied primarily for its potential neuroprotective and cognitive-enhancing effects. In several countries, notably Hungary and some parts of Eastern Europe, vinpocetine has been prescribed for the treatment of cognitive impairment, memory disorders, and symptoms such as confusion, particularly those associated with vascular dementia and cerebrovascular insufficiency. Its proposed mechanisms include improving cerebral blood flow, enhancing neuronal glucose and oxygen utilization, and exhibiting antioxidant properties. However, the scientific evidence supporting its use for confusion is limited. Several small randomized controlled trials and open-label studies from the 1980s and 1990s indicated some benefit in cognitive function and global clinical impression in patients with mild to moderate cognitive impairment, dementia, and post-stroke cognitive deficits. Yet, these studies often suffered from methodological limitations, small sample sizes, and inconsistent outcome measures. More recent systematic reviews and meta-analyses (e.g., Cochrane reviews) have concluded that there is insufficient high-quality evidence to firmly support vinpocetine's efficacy for treating confusion or cognitive impairment, though some modest improvements in cognitive scores have been observed. The ingredient is not widely recommended in current clinical guidelines, and its use remains controversial outside of specific regions. Thus, while there is some scientific rationale and historical clinical use, the overall evidence remains weak (rated 2/5).

More about vinpocetine
More about Confusion

Other ingredients used for Confusion

Other health conditions supported by vinpocetine

Products containing vinpocetine

Pure Encapsulations Vinpocetine 20 mg